Detection of circulating tumor cells

Detection of circulating tumor cells in sufferers with breast most cancers utilizing the conditionally reprogrammed cell tradition methodology and reverse transcription-PCR of hTERT and MAGE A1-6

The current research aimed to confirm the efficacy of the conditionally reprogrammed cell (CRC) tradition methodology for the detection of circulating tumor cells (CTCs) in breast most cancers. CTCs have been remoted from the peripheral blood of sufferers with breast most cancers, and tradition of the collected CTCs was carried out in response to the conditional reprogramming protocol.

  • Whole RNA was extracted from cultured CTCs, and the hTERT and MAGE A1-6 genes have been amplified utilizing reverse transcription-PCR (RT-PCR). As well as, RNA extraction from one other blood pattern was carried out and the expression of the 2 genes was analyzed by RT-PCR solely.
  • Following CRC tradition, grown CTCs have been noticed in 7 samples (23.3%). The CTC detection charges by RT-PCR for the hTERT and MAGE A1-6 genes in CTCs grown utilizing the CRC tradition methodology have been 26.7 and 10.0%, respectively.
  • The optimistic expression charges for the hTERT and MAGE genes in CTCs assessed by RT-PCR solely have been 44.1 and 23.5%, respectively. When combining the optimistic expression charges of RT-PCR solely and CRC tradition for the hTERT and MAGE A1-6 genes, CTC detection charges elevated to 53.Three and 23.3%, respectively. Moreover, when combining the optimistic expression charges of the 2 genes by both methodology, the CTC detection price was the best worth noticed.
  • In conclusion, the current research revealed the potential of CRC tradition within the detection of CTCs in breast most cancers. Moreover, a mixture of CRC tradition and RT-PCR for the hTERT and MAGE A1-6 genes is helpful in enhancing the detection price of CTCs within the blood.

oxfordpcs
oxfordpcs

GPR81 antibody

20R-GR038 50 ug
EUR 679
Description: Rabbit polyclonal GPR81 antibody

GPR81 Antibody

DF2766 200ul
EUR 304
Description: GPR81 antibody detects endogenous levels of total GPR81.

GPR81 Antibody

44942-100ul 100ul
EUR 252

GPR81 Antibody

44942-50ul 50ul
EUR 187

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

GPR81 Conjugated Antibody

C44942 100ul
EUR 397

Polyclonal Goat Anti-GPR81 / FKSG80 Antibody

APR16285G 0.1 mg
EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR81 / FKSG80 . This antibody is tested and proven to work in the following applications:

GPR81 Blocking Peptide

DF2766-BP 1mg
EUR 195

pDNR-Dual-GPR81

PVT17473 2 ug
EUR 231

GPR81 Blocking Peptide

20-abx063821
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

Polyclonal GPR81 Antibody (C-term)

APR16611G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR81 (C-term). This antibody is tested and proven to work in the following applications:

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

GPR81 ELISA KIT|Human

EF009971 96 Tests
EUR 689

Polyclonal FKSG80 / GPR81 Antibody (C-Terminus)

APR15995G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (Extracellular Domain)

APR15996G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (N-Terminus)

APR15997G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (N-Terminus). This antibody is tested and proven to work in the following applications:

Gpr81 ORF Vector (Rat) (pORF)

ORF067824 1.0 ug DNA
EUR 506

Gpr81 ORF Vector (Mouse) (pORF)

ORF046573 1.0 ug DNA
EUR 506

G Protein-Coupled Receptor 81 (GPR81) Antibody

abx430538-200ul 200 ul
EUR 384

G Protein-Coupled Receptor 81 (GPR81) Antibody

abx233610-100ug 100 ug
EUR 551

G Protein-Coupled Receptor 81 (GPR81) Antibody

20-abx147554
  • EUR 425.00
  • EUR 342.00
  • 100 ug
  • 50 ug

G Protein-Coupled Receptor 81 (GPR81) Antibody

20-abx008192
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

G Protein-Coupled Receptor 81 (GPR81) Antibody

abx028676-400ul 400 ul
EUR 523

G Protein-Coupled Receptor 81 (GPR81) Antibody

abx028676-80l 80 µl
EUR 286

Gpr81 sgRNA CRISPR Lentivector set (Rat)

K6130201 3 x 1.0 ug
EUR 339

Gpr81 sgRNA CRISPR Lentivector set (Mouse)

K3904701 3 x 1.0 ug
EUR 339

GPR81 sgRNA CRISPR Lentivector set (Human)

K0893201 3 x 1.0 ug
EUR 339

GPR81 3'UTR Luciferase Stable Cell Line

TU009183 1.0 ml
EUR 1521

Gpr81 3'UTR Luciferase Stable Cell Line

TU109042 1.0 ml Ask for price

Gpr81 3'UTR Luciferase Stable Cell Line

TU205392 1.0 ml Ask for price

Gpr81 3'UTR GFP Stable Cell Line

TU159042 1.0 ml Ask for price

Gpr81 3'UTR GFP Stable Cell Line

TU255392 1.0 ml Ask for price

GPR81 3'UTR GFP Stable Cell Line

TU059183 1.0 ml
EUR 1521

GPR81 Protein Vector (Rat) (pPB-C-His)

PV271294 500 ng
EUR 603

GPR81 Protein Vector (Rat) (pPB-N-His)

PV271295 500 ng
EUR 603

GPR81 Protein Vector (Rat) (pPM-C-HA)

PV271296 500 ng
EUR 603

GPR81 Protein Vector (Rat) (pPM-C-His)

PV271297 500 ng
EUR 603

GPR81 Protein Vector (Mouse) (pPB-C-His)

PV186290 500 ng
EUR 603

GPR81 Protein Vector (Mouse) (pPB-N-His)

PV186291 500 ng
EUR 603

GPR81 Protein Vector (Mouse) (pPM-C-HA)

PV186292 500 ng
EUR 603

GPR81 Protein Vector (Mouse) (pPM-C-His)

PV186293 500 ng
EUR 603

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6130202 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6130203 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6130204 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3904702 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3904703 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3904704 1.0 ug DNA
EUR 154

GPR81 sgRNA CRISPR Lentivector (Human) (Target 1)

K0893202 1.0 ug DNA
EUR 154

GPR81 sgRNA CRISPR Lentivector (Human) (Target 2)

K0893203 1.0 ug DNA
EUR 154

GPR81 sgRNA CRISPR Lentivector (Human) (Target 3)

K0893204 1.0 ug DNA
EUR 154

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6130205 3 x 1.0 ug
EUR 376

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3904705 3 x 1.0 ug
EUR 376

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0893205 3 x 1.0 ug
EUR 376

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6130206 1.0 ug DNA
EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6130207 1.0 ug DNA
EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6130208 1.0 ug DNA
EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3904706 1.0 ug DNA
EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3904707 1.0 ug DNA
EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3904708 1.0 ug DNA
EUR 167

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0893206 1.0 ug DNA
EUR 167

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0893207 1.0 ug DNA
EUR 167

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0893208 1.0 ug DNA
EUR 167

Anti-Anti-SEPT2 Antibody antibody

STJ25475 100 µl
EUR 277

Anti-Anti-SEPT5 Antibody antibody

STJ25477 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-SEPT8 Antibody antibody

STJ25479 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT2 Antibody antibody

STJ28365 100 µl
EUR 277

Anti-Anti-SEPT7 Antibody antibody

STJ28963 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT8 Antibody antibody

STJ117206 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT12 Antibody antibody

STJ117759 100 µl
EUR 277
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-MARCH6 Antibody antibody

STJ118549 100 µl
EUR 277

Anti-Anti-MARCH6 Antibody antibody

STJ118550 100 µl
EUR 277

Anti-Anti-MARCH7 Antibody antibody

STJ118752 100 µl
EUR 277

Anti-Anti-SEPT3 Antibody antibody

STJ118990 100 µl
EUR 277

Anti-Anti-SEPT1 antibody antibody

STJ119580 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]

Anti-Anti-SEPT7 Antibody antibody

STJ116214 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT6 antibody antibody

STJ11100949 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.

Anti-Anti-SEPT9 Antibody antibody

STJ111369 100 µl
EUR 277
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Anti-Anti-SEPT11 Antibody antibody

STJ111530 100 µl
EUR 277

Anti-Anti-SEPT4 Antibody antibody

STJ112276 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.

Anti-Anti-MARCH9 Antibody antibody

STJ112609 100 µl
EUR 277

Anti-Anti-SEPT11 Antibody antibody

STJ113941 100 µl
EUR 277

Anti-Anti-SEPT11 Antibody antibody

STJ114081 100 µl
EUR 277

Anti-Anti-SEPT5 Antibody antibody

STJ114819 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-MARCH8 Antibody antibody

STJ114828 100 µl
EUR 277

Anti-Anti-DDB1 Antibody

A00333 100uL
EUR 455
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit

AEA465Hu-10x96wellstestplate 10x96-wells test plate
EUR 5647.8
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit

AEA465Hu-1x48wellstestplate 1x48-wells test plate
EUR 552.76
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit

AEA465Hu-1x96wellstestplate 1x96-wells test plate
EUR 746.8
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit

AEA465Hu-5x96wellstestplate 5x96-wells test plate
EUR 3060.6
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit

4-AEA465Hu
  • EUR 5698.00
  • EUR 3011.00
  • EUR 747.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody)

ELK8071 1 plate of 96 wells
EUR 432
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Anti- ZNF660 antibody

ABD2410 100 ug
EUR 438


Incidence, scientific course and threat issue for recurrent PCR positivity in discharged COVID-19 sufferers in Guangzhou, China: A potential cohort research

The phenomenon of COVID-19 sufferers examined optimistic for SARS-CoV-2 after discharge (redetectable as optimistic, RP) emerged globally. The information of incidence price and threat elements for RP occasion and the scientific options of RP sufferers might present suggestions for virus containment and circumstances administration for COVID-19.

We prospectively collected and analyzed the epidemiological, scientific and virological information from 285 grownup sufferers with COVID-19 and bought their particular scientific final result (getting PCR optimistic or not throughout post-discharge surveillance). By March 10, 27 (9.5%) discharged sufferers had examined optimistic for SARS-CoV-2 of their nasopharyngeal swab after a median length of seven·Zero days (IQR 5·0-8·0).

In comparison with first admission, RP sufferers typically had milder scientific signs, decrease viral load, shorter size of keep and improved pulmonary circumstances at readmission (p<0.05). Elder RP sufferers (≥ 60 years previous) have been extra prone to be symptomatic in comparison with youthful sufferers (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission.

Age, intercourse, epidemiological historical past, scientific signs and underlying illnesses have been related between RP and non-RP sufferers (p>0.05). A protracted length of viral shedding (>10 days) throughout the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50-13.57 for N gene; aOR: 9.64, 95% CI: 3.91-23.73 for ORF gene] and better Ct worth (ORF) within the third week of the primary hospitalization (aOR: 0.69; 95% CI: 0.50-0.95) have been related to RP occasions.

In conclusion, RP occasions occurred in practically 10% of COVID-19 sufferers shortly after the detrimental checks, weren’t related to worsening signs and unlikely mirror reinfection. Sufferers’ lack of effectivity in virus clearance was a threat issue for RP end result. It’s noteworthy that elder RP sufferers (≥ 60 years previous) have been extra vulnerable to scientific signs at readmission.

Ovine Paratuberculosis: Seroprevalence and comparability of fecal tradition and direct fecal PCR assay

Johne’s illness is persistent, incurable illness, brought on by Mycobacterium avium subsp. paratuberculosis (MAP). Most research in Egypt targeted on incidence of the illness in cattle however few research have been reported presence of antibodies towards MAP in sheep. The current research decided the seroprevalence price of MAP amongst sheep in 4 Governorates and assessed the related threat elements to MAP-infection.

  • The seroprevalence price of MAP amongst sheep was non-significant various between totally different Governorates, it was ranged between 3.75%-12.3%. The outcomes revealed that the seroprevalence price of the illness was considerably elevated in diarrheic sheep (11 %, 95 %CI: 7.2-16.2) throughout spring (15 %, 95 %CI: 8.3-25) and summer time (8%, 95 %CI: 4.13-13.8) seasons.
  • Opposite, the age of sheep and make contact with with different ruminants like cattle or goats had non-significant impact of spreading of MAP-infection amongst sheep. The detection of MAP in feces of sheep was carried out utilizing tradition and PCR to find out the effectivity of each checks.
  • The kappa check revealed good settlement between each checks for detection of MAP. The obtained discovering confirms the presence of MAP amongst sheep in Egypt. So, the suitable management measures ought to be taken to scale back spreading of the illness amongst sheep and cut back its financial losses.

Bax Blocking Peptide

AF0083-BP 1mg
EUR 195

hnRPD Blocking Peptide

AF0092-BP 1mg
EUR 195

eNOS Blocking Peptide

AF0096-BP 1mg
EUR 195

HSF1 Blocking Peptide

AF0098-BP 1mg
EUR 195

TTK Blocking Peptide

AF0102-BP 1mg
EUR 195

FRS2 Blocking Peptide

AF0103-BP 1mg
EUR 195

Gab2 Blocking Peptide

AF0106-BP 1mg
EUR 195

APLF Blocking Peptide

AF0108-BP 1mg
EUR 195

RAD17 Blocking Peptide

AF0110-BP 1mg
EUR 195

RON Blocking Peptide

AF0111-BP 1mg
EUR 195

APAF1 Blocking Peptide

AF0117-BP 1mg
EUR 195

ARC Blocking Peptide

AF0118-BP 1mg
EUR 195

Bak Blocking Peptide

AF0119-BP 1mg
EUR 195

Bax Blocking Peptide

AF0120-BP 1mg
EUR 195

BIM Blocking Peptide

AF0121-BP 1mg
EUR 195

CARD6 Blocking Peptide

AF0123-BP 1mg
EUR 195

Fos Blocking Peptide

AF0132-BP 1mg
EUR 195

Cox1 Blocking Peptide

AF0138-BP 1mg
EUR 195

Desmin Blocking Peptide

AF0147-BP 1mg
EUR 195

TFDP1 Blocking Peptide

AF0149-BP 1mg
EUR 195

Dysferlin Blocking Peptide

AF0150-BP 1mg
EUR 195

E2F4 Blocking Peptide

AF0151-BP 1mg
EUR 195

E2F6 Blocking Peptide

AF0152-BP 1mg
EUR 195

ERCC1 Blocking Peptide

AF0154-BP 1mg
EUR 195

FASL Blocking Peptide

AF0157-BP 1mg
EUR 195

FGFR2 Blocking Peptide

AF0159-BP 1mg
EUR 195

FGFR3 Blocking Peptide

AF0160-BP 1mg
EUR 195

FLI1 Blocking Peptide

AF0161-BP 1mg
EUR 195

GABBR1 Blocking Peptide

AF0162-BP 1mg
EUR 195

GAD1 Blocking Peptide

AF0163-BP 1mg
EUR 195

GANP Blocking Peptide

AF0165-BP 1mg
EUR 195

mGluR4 Blocking Peptide

AF0168-BP 1mg
EUR 195

GluR5 Blocking Peptide

AF0169-BP 1mg
EUR 195

mGluR6 Blocking Peptide

AF0170-BP 1mg
EUR 195

mGluR7 Blocking Peptide

AF0171-BP 1mg
EUR 195

mGluR8 Blocking Peptide

AF0172-BP 1mg
EUR 195

GLUT1 Blocking Peptide

AF0173-BP 1mg
EUR 195

GLUT3 Blocking Peptide

AF0174-BP 1mg
EUR 195

GRP75 Blocking Peptide

AF0176-BP 1mg
EUR 195

HDAC1 Blocking Peptide

AF0178-BP 1mg
EUR 195

HDAC10 Blocking Peptide

AF0179-BP 1mg
EUR 195

HDAC7 Blocking Peptide

AF0180-BP 1mg
EUR 195

HDAC9 Blocking Peptide

AF0181-BP 1mg
EUR 195

HSP10 Blocking Peptide

AF0183-BP 1mg
EUR 195

HSP60 Blocking Peptide

AF0184-BP 1mg
EUR 195

Involucrin Blocking Peptide

AF0186-BP 1mg
EUR 195

COPS3 Blocking Peptide

AF0187-BP 1mg
EUR 195

JM4 Blocking Peptide

AF0188-BP 1mg
EUR 195

Ki67 Blocking Peptide

AF0198-BP 1mg
EUR 195

iNOS Blocking Peptide

AF0199-BP 1mg
EUR 195

Ku80 Blocking Peptide

AF0200-BP 1mg
EUR 195

Ku70 Blocking Peptide

AF0201-BP 1mg
EUR 195

Mammaglobin Blocking Peptide

AF0202-BP 1mg
EUR 195

MLANA Blocking Peptide

AF0204-BP 1mg
EUR 195

MCL1 Blocking Peptide

AF0205-BP 1mg
EUR 195

MCM2 Blocking Peptide

AF0206-BP 1mg
EUR 195

MCM5 Blocking Peptide

AF0207-BP 1mg
EUR 195

MDM2 Blocking Peptide

AF0208-BP 1mg
EUR 195

MMP1 Blocking Peptide

AF0209-BP 1mg
EUR 195

MMP11 Blocking Peptide

AF0211-BP 1mg
EUR 195

MMP14 Blocking Peptide

AF0212-BP 1mg
EUR 195

MMP15 Blocking Peptide

AF0213-BP 1mg
EUR 195

MMP16 Blocking Peptide

AF0214-BP 1mg
EUR 195

MMP19 Blocking Peptide

AF0215-BP 1mg
EUR 195

MMP23 Blocking Peptide

AF0216-BP 1mg
EUR 195

MMP3 Blocking Peptide

AF0217-BP 1mg
EUR 195

MMP7 Blocking Peptide

AF0218-BP 1mg
EUR 195

MMP8 Blocking Peptide

AF0219-BP 1mg
EUR 195

MMP9 Blocking Peptide

AF0220-BP 1mg
EUR 195

NKX3.1 Blocking Peptide

AF0221-BP 1mg
EUR 195

NM23 Blocking Peptide

AF0222-BP 1mg
EUR 195

NSE Blocking Peptide

AF0223-BP 1mg
EUR 195

OCT1 Blocking Peptide

AF0224-BP 1mg
EUR 195

OCT2 Blocking Peptide

AF0225-BP 1mg
EUR 195

OCT3 Blocking Peptide

AF0226-BP 1mg
EUR 195

Osteopontin Blocking Peptide

AF0227-BP 1mg
EUR 195

PCAF Blocking Peptide

AF0231-BP 1mg
EUR 195

p63 Blocking Peptide

AF0233-BP 1mg
EUR 195

Parkin Blocking Peptide

AF0235-BP 1mg
EUR 195

Patched Blocking Peptide

AF0237-BP 1mg
EUR 195

PCNA Blocking Peptide

AF0239-BP 1mg
EUR 195

PDGFB Blocking Peptide

AF0240-BP 1mg
EUR 195

PDGFRalpha Blocking Peptide

AF0241-BP 1mg
EUR 195

Peripherin Blocking Peptide

AF0242-BP 1mg
EUR 195

PGP9.5 Blocking Peptide

AF0243-BP 1mg
EUR 195

KCNC2 Blocking Peptide

AF0244-BP 1mg
EUR 195

KLK3 Blocking Peptide

AF0246-BP 1mg
EUR 195

RCBTB1 Blocking Peptide

AF0248-BP 1mg
EUR 195

RIT1 Blocking Peptide

AF0250-BP 1mg
EUR 195

SHIP1 Blocking Peptide

AF0252-BP 1mg
EUR 195

SHPS1 Blocking Peptide

AF0253-BP 1mg
EUR 195

SNAP25 Blocking Peptide

AF0254-BP 1mg
EUR 195